血管老化发生机制及相关靶点的研究进展

doi:10.3969/j.issn.1003-9198.2021.07.024

摘要/Abstract

中图分类号:

R 543

王凯, 范小璇, 王欢, 杨永锋, 马思田, 赵晓平. 血管老化发生机制及相关靶点的研究进展[J]. 实用老年医学, 2021, 35(7): 750-753.

[1] SUN Z J. Aging, arterial stiffness, and hypertension[J]. Hypertension, 2015, 65(2):252-256.
[2] MARUHASHI T, KAJIKAWA M, KISHIMOTO S, et al. Vascular function is further impaired in subjects aged 80 years or older[J]. Hypertens Res, 2020, 43(9):914-921.
[3] CAHILL-SMITH S, LI J M. Oxidative stress, redox signalling and endothelial dysfunction in ageing‐related neurodegenerative diseases: a role of NADPH oxidase 2[J]. Br J Clin Pharmacol, 2014,78(3):441-453.
[4] FUKUTOMI M, KARIO K.Aging and hypertension[J].Expert Rev Cardiovasc Ther, 2016, 8 (11):1531-1539.
[5] GHAVAMPOUR S,KLEEFELDT F,BÖMMEL H,et al.Endothelial barrier function is differentially regulated by CEACAM1-mediated signaling[J]. FASEB J, 2018, 32(10): 5612-5625.
[6] KLEEFELDT F, RUECKSCHLOSS U, ERGUN S.CEACAM1 promotes vascular aging processes[J]. Aging: Albany NY, 2020,12(4):3121-3123.
[7] YEO T W,LAMPAH D A,KENANGALEM E, et al.Impaired systemic tetrahydrobiopterin bioavailability and increased dihydrobiopterin in adult falciparum malaria: association with disease severity, impaired microvascular function and increased endothelial activation[J]. PLoS Pathog, 2015, 11(3):e1004667.
[8] STEPPAN J,BERGMAN Y,VIEGAS K,et al.Tissue transglutaminase modulates vascular stiffness andfunction through crosslinking-dependent and crosslinking independent functions[J]. J Am Heart Assoc,2017, 6(2):e004161.
[9] FARAH C,MICHEL L Y M,BALLIGAND J L.Nitric oxide signalling in cardiovascular health and disease[J]. Nat Rev Cardiol, 2018, 15(5):292-316.
[10] JING X,LEI Y,WANG Q,et al.The relationship between telomere,telomerase and vascular aging[J]. J Cardiovas Cerebrovascular Dis,2015, 10(7):893-896.
[11] WANG M Y,WANG H H,LAKATTA E G,et al.Milk fat globule epidermal growth factor Ⅷ signaling in arterial wall remodeling[J]. Curr Vasc Pharmacol,2013, 11(5):768-769.
[12] YANG D,XIAO C X,LONG F,et al.Fra-1 plays a critical role in angiotensin II-induced vascular senescence[J]. FASEB J, 2019, 33(6): 7603-7614.
[13] LAZARO I,OGUIZA A,RECIO C,et al. Targeting HSP90 ameliorates nephropathy and atherosclerosis through suppression of NF-κB and STAT signaling pathways in diabetic Mice[J]. Diabetes, 2015, 64(10):3600-3613.
[14] KLEEFELDT F,BOMMEL H,BROEDE B,et al.Aging-related carcinoembryonic antigen-related cell adhesion molecule 1 signaling promotes vascular dysfunction[J].Aging Cell,2019,18(6): e13025.
[15] RUECKSCHLOSS U,KUERTEN S,ERGUN S. The role of CEA-related cell adhesion molecule-1(CEACAM1) in vascular homeostasis[J].Histochem Cell Biol,2016,146(6): 657-671.
[16] OKADOME J,MATSUMOTO T,YOSHIYA K,et al.BubR1 insufficiency impairs angiogenesis in aging and in experimental critical limb ischemic mice[J]. J Vasc Surg,2018,68(2):576-586.
[17] QADIR M I,ANWAR S. Sirtuins in brain aging and neurological disorders[J]. Crit Rev Eukaryot Gene Expr,2017,27(4):321-329.
[18] GANO L B,DONATO A J,PASHA H M,et al.The SIRT1 activator SRT1720 reverses vascular endothelial dysfunction, excessive superoxide production, and inflammation with aging in mice[J]. Am J Physiol Heart Circ Physiol,2014,307(12):H1754-H1763.
[19] BHULLAR K S,HUBBARD B P.Lifespan and healthspan extension by resveratrol[J]. Biochim Biophys Acta,2015,1852(6):1209-1218.
[20] DE PICCIOTTO N E,GANO L B,JOHNSON L C,et al.Nicotinamide mononucleotide supplementation reverses vascular dysfunction and oxidative stress with aging in mice[J]. Aging Cell, 2016, 15(3):522-530.
[21] YAO H, HWANG J W, SUNDAR I K, et al.SIRT1 redresses the imbalance of tissue inhibitor of matrix metalloproteinase-1 and matrix metalloproteinase-9 in the development of mouse emphysema and human COPD[J]. Am J Physiol Lung Cell Mol Physiol, 2013, 305(9):L615-L624.
[22] CHENG L J, ZHANG L, YANG J, et al.Activation of peroxisome proliferator-activated receptor γ inhibits vascular calcification by upregulating Klotho[J]. Exp Ther Med, 2017,13(2):467-474.
[23] MALTESE G,FOUNTOULAKIS N,SIOW R C,et al.Perturbations of the anti-ageing hormone Klotho in patients with type 1 diabetes and microalbuminuria[J]. Diabetologia,2017,60(5):911-914.
[24] DONATO A J,MACHIN D R,LESNIEWSKI L A.Mechanisms of dysfunction in the aging vasculature and role in age-related disease[J]. Circ Res,2018,123(7):825-848.
[25] GE D, HAN L, HUANG S Y, et al.Identification of a novel MTOR activator and discovery of a competing endogenous RNA regulating autophagy in vascular endothelial cells[J]. Autophagy,2014,10(6):957-971.
[26] SUNG J Y, LEE K Y, KIM J R, et al.Interaction between mTOR pathway inhibition and autophagy induction attenuates adriamycin-induced vascular smooth muscle cell senescence through decreased expressions of p53/p21/p16[J]. Exp Gerontol,2018,109:51-58.
[27] TAN P, WANG Y J, LI S, et al.The PI3K/Akt/mTOR pathway regulates the replicative senescence of human VSMCs[J]. Mol Cell Biochem, 2016, 422(1/2):1-10.
[28] DONG D,CAI G Y,NING Y C,et al.Alleviation of senescence and epithelial-mesenchymal transition in aging kidney by short-term caloric restriction and caloric restriction mimetics via modulation of AMPK/mTOR signaling[J]. Oncotarget, 2017, 8(10):16109-16121.
[29] DONATO A J,MACHIN D R,LESNIEWSKI L A. Mechanisms of dysfunction in the aging vasculature and role in age-related disease[J]. Circ Res,2018,123(7):825-848.
[30] WANG M, FU Y, GAO C, et al.Cartilage oligomeric matrix protein prevents vascular aging and vascular smooth muscle cells senescence[J]. Biochem Biophys Res Commun,2016,478(2):1006-1013.
[31] ZHOU Z, YIN Y, CHANG Q, et al.Downregulation of B-myb promotes senescence via the ROS-mediated p53/p21 pathway, in vascular endothelial cells[J]. Cell Prolif, 2017,50(2):e12319.

血管老化发生机制及相关靶点的研究进展

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

推荐阅读 10

[1]	陈映泉, 钟勇. 心血管老化的机制、标志物和治疗[J]. 实用老年医学, 2024, 38(3): 299-303.
[2]	范婷泳, 袁丽, 杨小玲, 陈茜. Caprini量表评估老年糖尿病病人静脉血栓栓塞症的效果[J]. 实用老年医学, 2023, 37(12): 1233-1237.
[3]	张授尧, 张星贺, 夏世金. 血管衰老与老年血管疾病[J]. 实用老年医学, 2023, 37(10): 973-977.
[4]	白晓瑜, 张君, 赵鹏, 魏梅, 邱亚辉, 冯雪娟. 5次坐立试验与老年PCI病人心功能及生活质量的相关性研究[J]. 实用老年医学, 2023, 37(8): 777-780.
[5]	高伟飞, 李鹏, 乔镇, 马利娜. Padua评分对老年住院病人发生静脉血栓栓塞症的预测价值[J]. 实用老年医学, 2023, 37(8): 803-805.
[6]	王朝阳, 赵丽娜, 梁浩, 陈淑霞, 谷剑. 纤维蛋白原与白蛋白比值对老年疑似冠心病病人冠脉病变程度的预测价值[J]. 实用老年医学, 2023, 37(8): 806-810.
[7]	杨少琦, 杨洋, 邓丽娜, 翟志欣. 系统免疫炎症指数对老年射血分数减低型心力衰竭病人下肢深静脉血栓形成的预测价值[J]. 实用老年医学, 2023, 37(7): 695-699.
[8]	陈顺中. 慢性脑供血不足的中医治疗研究进展[J]. 实用老年医学, 2023, 37(2): 124-127.
[9]	崔娟, 郑俊晨. 外周血尿路上皮癌抗原1、脂蛋白(a)在老年急性心肌梗死病人中的诊断价值[J]. 实用老年医学, 2021, 35(12): 1273-1276.
[10]	周艳, 翁艳敏. 1例老年主动脉穿透性溃疡合并颈动脉夹层并发急性脑动脉栓塞的护理[J]. 实用老年医学, 2021, 35(11): 1209-1211.
[11]	张玥, 谭晓. 冠状动脉慢血流现象临床相关危险因素分析[J]. 实用老年医学, 2021, 35(10): 1019-1022.
[12]	郭万申, 樊双义. 老年心脑血管疾病病人颈动脉斑块与体质量指数、生长激素之间的关系[J]. 实用老年医学, 2021, 35(9): 935-938.
[13]	王铭, 孙瑞红. 巨噬细胞极化在动脉粥样硬化进程中的研究进展[J]. 实用老年医学, 2021, 35(9): 975-977.
[14]	袁凯晴, 姜晓艳. 血清β2微球蛋白在心脑血管疾病中的研究进展[J]. 实用老年医学, 2021, 35(8): 879-882.
[15]	殷亚昕, 刘润梅, 翟红霞, 李良, 张津津, 陈海威, 王磊, 李娜, 夏云峰. 辛伐他汀对动脉粥样硬化大鼠高迁移率族蛋白1表达的影响[J]. 实用老年医学, 2010, 24(2): 128-131.